Loading organizations...

§ Private Profile · Seattle, WA, USA
Makers of simple, affordable medical devices. Our award-winning…
Shift Labs has raised $1.0M across 1 funding round.
Key people at Shift Labs.
Shift Labs was founded in 2012 by Beth Kolko (Founder/CEO).
Shift Labs has raised $1.0M in total across 1 funding round.
Shift Labs makes medical devices that place technology and design on equal footing to create affordable solutions. We emphasize simplicity and create devices that serve the fastest growing healthcare markets in the world.
We believe that every person in the world deserves quality healthcare -- whether they are receiving care in the home, in an outpatient infusion center, or in an emerging market.
We're a for-profit company committed to doing well, and doing good.
We believe Simple Saves Lives.
___
In true startup fashion, we have a strategy that emphasizes early revenue. So check out our first product DripAssist, a low-cost IV fluid monitor and alarm. Get precision monitoring of blood transfusions or fluid delivery at a fraction of the cost of an infusion pump. Purchase at http://www.shiftlabs.com/purchase-dripassist
Key people at Shift Labs.
Shift Labs has raised $1.0M across 1 funding round. Most recently, it raised $1.0M ShiftLabs - Seed in July 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 1, 2015 | $1M Seed | — | Adverb Ventures, Foundation Capital, Hoxton Ventures, Kleiner Perkins, Social Capital, Visionaire Ventures, Ellen PAO, Theresa Johnson | Announced |
Shift Labs was founded in 2012 by Beth Kolko (Founder/CEO).
Shift Labs has raised $1.0M in total across 1 funding round.
Shift Labs's investors include Adverb Ventures, Foundation Capital, Hoxton Ventures, Kleiner Perkins, Social Capital, Visionaire Ventures, Ellen Pao, Theresa Johnson.
Shift Labs is a Seattle-based medical device company specializing in simple, affordable infusion therapy solutions, primarily through its flagship product, the DripAssist Infusion Rate Monitoring Platform. This FDA-cleared device enables safe, accurate, and remote monitoring of gravity IV infusions, serving diverse healthcare settings including home care, hospitals, veterinary care, and emerging markets. By providing precise infusion monitoring at a fraction of the cost of traditional infusion pumps, Shift Labs addresses critical patient safety and operational efficiency challenges in infusion therapy. The company has demonstrated strong growth momentum, notably doubling revenue during the COVID-19 pandemic due to increased reliance on gravity infusion and expanding its connected device offerings across multiple markets[1][4][5].
Founded in 2012 by Beth Kolko, a University of Washington professor and experienced entrepreneur, Shift Labs emerged from a vision to create well-designed, affordable medical devices that balance technology and design. The idea was driven by the need for accessible healthcare solutions that serve fast-growing markets, from home health care in the US to clinical care in emerging economies. Early recognition came with the DripAssist device being named one of Popular Science Magazine’s 12 Best Healthcare Innovations of 2016 and receiving multiple awards and grants, including funding from USAID and the US Air Force. These milestones validated the product’s impact and helped the company gain traction in both developed and emerging healthcare sectors[1][4].
Shift Labs rides the growing trend of decentralizing healthcare delivery and increasing demand for affordable, connected medical devices that enable remote patient monitoring. The timing is critical as healthcare systems worldwide face pressures to reduce costs while improving patient safety, especially in the wake of the COVID-19 pandemic which accelerated reliance on gravity IV infusions. Market forces such as aging populations, rising chronic disease prevalence, and expansion of home and outpatient care settings favor Shift Labs’ solutions. By providing actionable data insights and enabling value-based care, Shift Labs influences the broader ecosystem by bridging technology, design, and global health needs, particularly in underserved regions[1][5].
Shift Labs is poised for continued growth as it expands its connected device platform across acute and non-acute care markets. Future trends shaping its journey include increased adoption of remote monitoring technologies, integration with digital health platforms, and growing emphasis on cost-effective care delivery in emerging markets. As healthcare moves toward more data-driven, patient-centered models, Shift Labs’ emphasis on simplicity, affordability, and design positions it to deepen its influence in infusion therapy and beyond. The company’s commitment to doing well financially while doing good socially suggests a sustainable path forward, reinforcing its founding mission that *Simple Saves Lives*[4][5].